Herlev Hospital
Clinical trials sponsored by Herlev Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Online training could sharpen Pathologists' eye for melanoma Results expected Dec 2026 (estimated)
- Targeted radiation aims to cure prostate cancer while sparing healthy tissue Results expected May 2027 (estimated)
- Zinc pills could help seniors fight infections after hospital stay Results expected May 2027 (estimated)
- Kidney Patients' bone loss targeted in new hormone study Results expected Sep 2027 (estimated)
-
Personalized drug matching put to the test in pancreatic cancer
Disease control Not yet recruitingThis phase 2 trial tests whether choosing treatment based on the genetic changes in a person's pancreatic cancer works better than standard chemotherapy. Adults with advanced pancreatic cancer that has progressed after first-line treatment may join if their tumor has a genetic ch…
Phase 2 • Sponsor: Herlev Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Zinc pills could help seniors fight infections after hospital stay
Disease control Not yet recruitingThis study tests whether a daily 22 mg zinc supplement for 12 months can lower inflammation and reduce infections in adults aged 65 and older who were recently hospitalized. Researchers will measure blood markers, infection rates, hospital readmissions, and quality of life. 220 p…
Sponsor: Herlev Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Online training could sharpen Pathologists' eye for melanoma
Knowledge-focused Not yet recruitingThis study tests whether an online training platform called DermLoop Learn can improve how pathologists diagnose melanoma from skin lesion images. 258 pathologists will be randomly assigned to receive the training or not, and their diagnostic accuracy will be compared against a p…
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC